Which is more profitable, Amgen or Thermo Fisher Scientific?

Amgen keeps more of every sale as profit.

Which grows faster, Amgen or Thermo Fisher Scientific?

Amgen grew its sales faster in recent years.

Which is cheaper, Amgen or Thermo Fisher Scientific?

Amgen costs less for each unit of yearly profit (lower P/E).

Which has less debt, Amgen or Thermo Fisher Scientific?

Thermo Fisher Scientific would need fewer years of earnings to pay off its debt.

AmgenAMGNvs

Thermo Fisher ScientificTMO

Amgen vs Thermo Fisher Scientific stock

Side by side in plain words: who keeps more of its sales, grows faster, costs less and owes less.

In one sentence

Amgen is more profitable, grows faster and is cheaper for its profits. Thermo Fisher Scientific has less debt.

Side by side

	Amgen	Thermo Fisher Scientific
	$252 billion	$259 billion
	21.0%	15.0%
	+7.6%	+6.7%
	32.7×	38.7×
	2.7 years	2.6 years
	15.0%	7.6%
	2.9%	0.4%

Open Amgen Open Thermo Fisher Scientific

How we compare

Four contests with the same rules as each stock page: profit kept from sales (higher wins), yearly sales growth across the last reports, up to five years (higher wins), price per unit of yearly profit (lower P/E wins; a company without profit loses) and debt in years of earnings (lower wins). A winner is only named when both companies have the number.

More comparisons: Amgen vs UnitedHealth · Amgen vs AbbVie · Amgen vs Bristol-Myers Squibb · Amgen vs Gilead Sciences · Thermo Fisher Scientific vs Bristol-Myers Squibb · Thermo Fisher Scientific vs Intuitive Surgical · Thermo Fisher Scientific vs Johnson & Johnson · Thermo Fisher Scientific vs Eli Lilly